Needham Capital Partners
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Nuvation Bio
32Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Disc Medicine | Biotech | Active | — | — |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#55
Co-investors
- Foresite CapitalVenture capital3 shared
- Biotechnology Value FundVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Logos CapitalVenture capital2 shared
- Redmile GroupVenture capital2 shared
- Altitude Life Science VenturesVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
- Asahi Kasei Corporate Venture CapitalVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.